CHA Biotech subsidiary CMG Pharmaceutical announced on the 16th that it has obtained item approval for the schizophrenia treatment 'Mezofy' (formerly Depipzo) from the U.S. Food and Drug ...

Mezofy, an oral film-type medication for treating schizophrenia developed by CMG Pharmaceutical, received approval from the U.S. Food and Drug Administration (FDA), the CHA Biotech subsidiary said ...

Aripiprazole is a generic prescription drug used to treat certain mental health conditions. It’s also available as the brand-name drug Abilify. Aripiprazole can cause side effects that range from mild ...

CMG Pharmaceutical, a chemical drug affiliate of CHA Biotech, has received approval from the U.S. Food and Drug Administration (FDA) for its schizophrenia treatment, Mezofy, the company said Wednesday ...